Tango Biosciences Inc Profile last edited on: 7/11/2023
CAGE: 7T3X7
UEI: RDG9AVNDS6N5
Business Identifier: Affinity reagents and sanwich assay technologies 
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
Location: Single
Congr. District: 07
County: Cook
Congr. District: 07
County: Cook
Public Profile
Tango Biosciences has developed a method for the discovery of recombinant affinity reagents through phage-display, which creates "sandwich" assay that increases both sensitivity and specificity. The solution, MegaSTAR, identifies two-site capable binders (i.e., pairs) as part of the phage-display affinity selection process. By relying upon two independent affinity reagents that recognize distinct epitopes, the sandwich assay increases both sensitivity and specificity. The company also produces fresh biomarkers and proteins using bacterial and mammalian cell culture and in vitro transcription and translation.
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
1-4Revenue Range
Less than .5MVC funded?
NoPublic/Private
Privately HeldStock Info
----IP Holdings
N/AAwards Distribution by Agency
Most Recent SBIR Projects
| Year | Phase | Agency | Total Amount | |
|---|---|---|---|---|
| 2023 | 1 | NIH | $275,606 | |
| Project Title: Generating fast-on rate reagents for lateral flow assays to detect HCV | ||||
| 2023 | 1 | NIH | $256,776 | |
| Project Title: High-throughput profiling of proteases with phage and arrays | ||||
| 2022 | 1 | NIH | $222,933 | |
| Project Title: Building a pipeline to generate affinity reagents to phosphothreonine epitopes | ||||
| 2021 | 1 | NIH | $222,329 | |
| Project Title: Building a Toolbox to Study the SARS-CoV-2 Proteome | ||||
| 2020 | 1 | NIH | $407,327 | |
| Project Title: Array Based Affinity Selection | ||||
Key People / Management
Brian Kenneth Kay -- Co-Founder
Joshua LaBaer
Hien-Anh Nguyen
Joshua LaBaer
Hien-Anh Nguyen
Company News
There are no news available.
